Palisade Bio, Inc. Common Stock
Symbol: PALI (NASDAQ)
1.74
▲ (0.81%) 0.014
Company Description:
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Key Stats
- Today's Open: $1.71
- Today's High: $1.875
- Today's Low: $1.705
- Today's Volume: 5.09M
- Yesterday Close: $1.73
- Yesterday High: $1.9
- Yesterday Low: $1.67
- Yesterday Volume: 5.64M
- Last Min Volume: 0
- Last Min High: $1.744
- Last Min Low: $1.744
- Last Min VWAP: $0
Company Profile
- Name: Palisade Bio, Inc. Common Stock
- Website: https://www.palisadebio.com
- Listed Date: 2021-04-28
- Location: CARLSBAD, CA
- Market Status: Active
- CIK Number: 0001357459
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $212.03M
- Round Lot: 100
- Outstanding Shares: 122.56M
- Asset Type: CS
RECENT FILINGS FOR PALI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-16 | 8-K | View |
| 2025-10-09 | 8-K | View |
| 2025-10-09 | SCHEDULE 13G | View |
| 2025-10-09 | SCHEDULE 13G | View |
| 2025-10-08 | 4 | View |
| 2025-10-08 | 4 | View |
| 2025-10-08 | 4 | View |
| 2025-10-08 | 4 | View |
| 2025-10-08 | 4 | View |
| 2025-10-08 | SCHEDULE 13G | View |
| 2025-10-08 | SCHEDULE 13G | View |
| 2025-10-08 | SCHEDULE 13G | View |
| 2025-10-07 | SCHEDULE 13G | View |
| 2025-10-07 | DEFA14A | View |
| 2025-10-02 | 424B4 | View |
| 2025-10-01 | S-1MEF | View |
| 2025-09-30 | EFFECT | View |
| 2025-09-29 | S-1 | View |
| 2025-09-26 | 8-K | View |
| 2025-09-18 | 8-K | View |
Latest News on PALI